$GRDN

📈 Chart

29 transactions across 3 dates · last 90 days

6-Month Buy/Sell Trend

Buys Sells
2026-03-28
20 other
⚡ 9 insiders
Insider Title Type Shares Price $ Value 10b5-1 Filed
Ackerman John M 1,413,939 Mar 31
Ackerman John M 471,057 Mar 31
Ackerman John M 1,413,939 Mar 31
Ackerman John M 471,057 Mar 31
BINDLEY WILLIAM E M 6,100,175 Mar 31
BINDLEY WILLIAM E M 6,100,175 Mar 31
Bindley Capital Partners I, LLC M 6,100,175 Mar 31
Bindley Capital Partners I, LLC M 6,100,175 Mar 31
Burke Fred See Remarks M 1,298,826 Mar 31
Burke Fred See Remarks M 1,298,826 Mar 31
Cardinal Equity Fund, L.P. M 471,057 Mar 31
Cardinal Equity Fund, L.P. M 471,057 Mar 31
Forbes Kendall See Remarks M 608,570 Mar 31
Forbes Kendall See Remarks M 608,570 Mar 31
Morris David K See Remarks M 641,869 Mar 31
Morris David K See Remarks M 641,869 Mar 31
Salentine Thomas J Jr M 6,100,175 Mar 31
Salentine Thomas J Jr M 6,100,175 Mar 31
Pharmacy Investors, LLC M 1,413,939 Mar 31
Pharmacy Investors, LLC M 1,413,939 Mar 31
2026-03-20
▼ 6 sells · $174.5M
⚡ 6 insiders
Insider Title Type Shares Price $ Value 10b5-1 Filed
Ackerman John / Pharmacy Investors, LLC ▼ Sell 827,636 $30 $24.6M Mar 24
BINDLEY WILLIAM E / Bindley Capital Partners I, LLC / Salentine Thomas J Jr ▼ Sell 3,570,677 $30 $106.0M Mar 24
Burke Fred See Remarks ▼ Sell 671,432 $30 $19.9M Mar 24
Cardinal Equity Fund, L.P. / Ackerman John ▼ Sell 275,728 $30 $8.2M Mar 24
Forbes Kendall See Remarks ▼ Sell 346,672 $30 $10.3M Mar 24
Morris David K See Remarks ▼ Sell 187,855 $30 $5.6M Mar 24
2026-02-11
3 other
⚡ 3 insiders
Insider Title Type Shares Price $ Value 10b5-1 Filed
Burke Fred See Remarks A 75,000 $0 $0 Feb 13
Forbes Kendall See Remarks A 50,000 $0 $0 Feb 13
Morris David K See Remarks A 50,000 $0 $0 Feb 13